This is what social media does, she says. It draws people in. It hurts people. In the worst cases, it kills people.
After decades of study, billions of dollars spent, and thousands of studies conducted, the failure to identify any genes for schizophrenia should definitively put to rest the notion that schizophrenia is a genetic disorder, according to E. Fuller Torrey.
Justin Karter interviews narrative and philosophical psychologist Mark Freeman about his vision for the future of psychology.
Revealing concerns about BetterHelp’s ability to provide quality, secure treatment—and the unresolved tensions in the science of psychotherapy that services like BetterHelp exploit.
The STAR*D Study has been cited as real-world evidence of the efficacy of antidepressants. In truth, it told of a failed paradigm of care.
In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.
Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric...
On the Mad in America podcast this week we have Robert Whitaker with us to answer questions sent in by readers and listeners.
In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.
In this interview, Audrey Clare Farley reveals how our understanding of schizophrenia was built to avoid acknowledging sexual trauma, religious abuse, and racism.
This is a call that challenges how psychiatry is practiced today and ultimately challenges its power in society.
May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem
Brooke Siem discusses her experiences of being medicated with antidepressants as a teenager, her withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects.
By embracing the widely popular technology-worship “religion,” psychiatry is permitted to ignore the reality that its repeated failures are evidence that its fundamental paradigm is misguided.
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.
In this interview with MIA's Justin Karter, psychiatrist Bradley Lewis discusses the value of art, the humanities, and mad studies in shaping a richer understanding of psychological experiences.
On the Mad in America podcast, we hear about the potential of lucid dreaming therapy to aid those struggling with post-traumatic stress.
Supporting a Child, Teen, or Young Person in Crisis - Our guest panel, Ciara Fanlo, Morna Murray and Sami Timimi join host Amy Biancolli to share stories of crisis but also stories of healing and of hope.
We have two guests today. One is Susan Swim, executive director of the Now I See A Person Institute, which she created in 2007...
The American Journal of Psychiatry Needs to Retract Study That Reported Fraudulent Results
Concerns rise about the adverse effects and longer-term harms of GLP-1 injections like Ozempic and Wegovy.
MIA's Justin Karter interviews Micha Frazer-Carroll about her new book, "Mad World: The Politics of Mental Health."
Following psychiatry’s repeated failures, a sane society would not give it increased status and power. However, our insane society uncritically accepts, celebrates, and worships anything promoted as technologies of control.
New data upends common beliefs about asylum closures, deinstitutionalization, and rates of psychiatric coercion.
Can Psychosocial Disability Transform Mental Health? A Conversation with Luis Arroyo and Justin Karter
Mad in Mexico's Luis Arroyo interviews MIA's Justin Karter about how psychosocial disability inclusion can transform Global Mental Health.
Price Hancock views the Thelen verdict as a partial win. "The jury agreed that the manufacturer 'failed to warn.’ That's huge. It's a step in the right direction."
The paradox of techno-optimism at a huge conference on the future of mental health led by embattled tech CEOs alongside the most prominent figures of psychiatry.